Wenjie Z. Liu

No. 3025 Shennan Zhong Road
Shenzhen, 518033, China

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 45 publications

Structure-Based Drug Design to Identify Potent, Selective, and Orally Available Cyclin-Dependent Kinase 9 Inhibitors for the Treatment of Castration-Resistant Prostate Cancer.

Structure-Based Drug Design to Identify Potent, Selective, and Orally Available Cyclin-Dependent Kinase 9 Inhibitors for the Treatment of Castration-Resistant Prostate Cancer.

Journal: Journal of medicinal chemistry
Published: May 04, 2026

Therapeutic strategies for the fatty-acid-binding pocket of the spike protein: advances and perspectives.

Therapeutic strategies for the fatty-acid-binding pocket of the spike protein: advances and perspectives.

Journal: Drug discovery today
Published: January 20, 2026

Transmembrane TNF-α signalling of macrophages drives pathological osteogenesis in radiographic axial spondyloarthritis.

Transmembrane TNF-α signalling of macrophages drives pathological osteogenesis in radiographic axial spondyloarthritis.

Journal: Annals of the rheumatic diseases
Published: January 12, 2026

Discovery of novel harmine derivatives as potent, selective, and brain permeable GSK3β inhibitors with effective In vivo anti-AD activity.

Discovery of novel harmine derivatives as potent, selective, and brain permeable GSK3β inhibitors with effective In vivo anti-AD activity.

Journal: European journal of medicinal chemistry
Published: September 23, 2025

IRF7 orchestrates proinflammatory macrophage polarization and joint destruction in rheumatoid arthritis.

IRF7 orchestrates proinflammatory macrophage polarization and joint destruction in rheumatoid arthritis.

Journal: Arthritis research & therapy
Published: September 04, 2025

Targeting chaperone-mediated autophagy to regulate osteoclast activity as a therapeutic strategy for osteoporosis.

Targeting chaperone-mediated autophagy to regulate osteoclast activity as a therapeutic strategy for osteoporosis.

Journal: Materials today. Bio
Published: March 30, 2025

Bioinformatics-Based Analysis of Ferroptosis-Related Biomarkers and the Prediction of Drugs Affecting the Adipogenic Differentiation of MSCs.

Bioinformatics-Based Analysis of Ferroptosis-Related Biomarkers and the Prediction of Drugs Affecting the Adipogenic Differentiation of MSCs.

Journal: Biomedicines
Published: March 12, 2025

The role of RAB12 in inhibiting osteogenic differentiation and driving metabolic dysregulation in osteoporosis.

The role of RAB12 in inhibiting osteogenic differentiation and driving metabolic dysregulation in osteoporosis.

Journal: Life sciences
Published: December 11, 2024

METTL9 mediated N1-Histidine methylation of SLC39A7 confers ferroptosis resistance and inhibits adipogenic differentiation in mesenchymal stem cells.

METTL9 mediated N1-Histidine methylation of SLC39A7 confers ferroptosis resistance and inhibits adipogenic differentiation in mesenchymal stem cells.

Journal: Molecular medicine (Cambridge, Mass.)
Published: October 24, 2024

Promotion of quiescence and maintenance of function of mesenchymal stem cells on substrates with surface potential.

Promotion of quiescence and maintenance of function of mesenchymal stem cells on substrates with surface potential.

Journal: Bioelectrochemistry (Amsterdam, Netherlands)
Published: October 16, 2024

ALG5 downregulation inhibits osteogenesis and promotes adipogenesis by regulating the N-glycosylation of SLC6A9 in osteoporosis.

ALG5 downregulation inhibits osteogenesis and promotes adipogenesis by regulating the N-glycosylation of SLC6A9 in osteoporosis.

Journal: Cellular and molecular life sciences : CMLS
Published: June 17, 2024

Correction: GAS5 protects against osteoporosis by targeting UPF1/SMAD7 axis in osteoblast differentiation.

Correction: GAS5 protects against osteoporosis by targeting UPF1/SMAD7 axis in osteoblast differentiation.

Journal: eLife
Published: April 25, 2024
Showing 1-12 of 45

Last Updated: 09/26/2026